- Duración
- 01/12/2020 - 28/02/2022
- Coordinador
- Jeffrey Lazarus
- Financiadores
- Gilead Sciences HBV-CARE Program
The objective of this study is to use point-of-care diagnostics in community settings to identify and link to care African (Ghanaian and Senegalese who are living in the greater Barcelona area) migrants infected with the hepatitis B virus (HBV). Specifically, this pilot study will utilize a novel rapid diagnostic test to screen for HBsAg, the dried blood spot (DBS) testing method to collect blood samples and transport to the laboratory, and will offer decentralized vaccination when appropriate for those who do not already have immunity.
This project is led by ISGlobal in collaboration with west African community members, Hospital Clínic de Barcelona, Hospital Universitari Vall d'Hebron, the Health Department of the Generalitat de Catalunya, the Public Health Agency of Barcelona, and the Microbiology Department of the Vall d'Hebron Research Institute (VHIR).
Nuestro equipo
Coordinator
- Jeffrey Lazarus Associate Research Professor
ISGlobal Team
- Camila Picchio Predoctoral Fellow
- Marcela Villota Research Assistant
- Emma Fernández Research Assistant
Otros proyectos
Ver proyectos pasadosHep C Free Baleares
Eliminating hepatitis C on the Balearic Islands (Mallorca, Menorca and Ibiza): a study in governmental and non-governmental addiction service centres, a mobile methadone unit and a prison to test and link people who use drugs to HCV care.
COMBACTE
Combatiendo la Resistencia Bacteriana en Europa
Evaluación de estrategias para la erradicación de la enfermedad del Pian
Erradicación del Pian
Novel Marine Biomolecules against Biofilm (NoMorFilm)
Application to medical devices
COMBACTE-CARE
Combatting Bacterial Resistance in Europe - Carbapenem Resistance
Prioritising Antimicrobial Resistance: establishing an interdisciplinary International Research Partnership to tackle an evolving global health threat
An interdisciplinary International Research Partnership to tackle an evolving global health threat
Development of new metal-antibiotics against pathogens causing chronic infections in patients with cystic fibrosis.
New metal-antibiotics for patients with cystic fibrosis
HU-MEN (High frequency Ultrasound-based MENingitis screening)
Non-invasive ultrasound-based screening for meningitis: Proof-of concept in infants
Xpatial-TB
Improved case detection through TB contact risk stratification by Xpert results and spatial parameters in Mozambique
WHIP3TB
Evaluation of the effect of weekly high dose rifapentine and isoniazid (3HP) vs periodic 3HP vs 6H for preventing TB among HIV-positive individuals
New antibacterial agents against 'Acinetobacter baumannii'
Search for new target proteins and use of antibacterial or inhibitory peptides against resistance mechanisms in 'Acinetobacter baumannii'
Desarrollo de nuevos metaloantibióticos frente a patógenos causantes de infecciones crónicas en pacientes con fibrosis quística
VINCI
Optimizing provider-initiated HIV testing, linkage, and retention in care in the district of Manhiça, Mozambique
INTE-AFRICA
Integrating and decentralizing diabetes and hypertension services in Africa
AVATAR
Searching the hidden: evaluating dengue, chikungunya and Zika autochthonous transmission in the city of Barcelona.
SAFE - Superbug Awareness For Education
COVID-PREG
Eficacia de hidroxicloroquina en la prevención de la infección por SARS-CoV-2 y de la gravedad de la enfermedad de COVID-19 durante el embarazo
SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT)
Estudio piloto para evaluar el potencial de la ivermectina para reducir la transmisión de COVID-19
Encuesta serológica Cendea de Cizur
Cendea de Cizur
CoViproteHCt
Projecte de Recerca en Resposta Immunitària i Epidemiologia de Malalties Infeccioses
Conèixer la propagació. Entendre la protecció
AMR DetecTool
A breakthrough device for the rapid detection of antimicrobial resistance
ANTICOV
Large Clinical Trial in Africa on the Treatment of Mild Cases of COVID-19
Stool4TB
Evaluating a new stool based qPCR for diagnosis of tuberculosis in children and people living with HIV
CAPTB
Close the Gap, Increase Access, Provide Adequate Therapy